Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Cascadian Therapeutics Inc

CUSIP: 14740B901 | 5 institutional holders

Quarters

Q4 2016 Q3 2016 Q2 2016

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile